Private label supplements in Europe: the 2026 manufacturer sourcing guide

Private label supplements are how most supplement brands graduate from “off-the-shelf product” to “something defensible.” The model — start with a manufacturer’s stock formula, add a layer of customization, negotiate some level of exclusivity — is the middle ground between fast white label launches and full custom formulation. For supplement brands in Europe, private label is where 60–70% of revenue typically sits at scale.

This guide covers what private label supplements actually are, how to choose a European private label supplement manufacturer, realistic MOQs and costs, EU regulatory considerations, the contract clauses that decide ownership and exclusivity, and concrete product examples. It is written for supplement brand founders, operators, and procurement teams sourcing private label supplements in Europe.

What private label supplements are

Private label supplements are dietary supplement products built on a manufacturer’s existing formula, customized for a specific brand, and sold under that brand’s name. The supplement brand handles positioning, marketing, and distribution. The supplement manufacturer handles formulation, production, regulatory documentation, and packaging.

The customization layer is what distinguishes private label from white label. A white label supplement is the manufacturer’s stock formula sold to any brand without modification. A private label supplement is a stock formula adjusted for the brand — custom flavor, custom dosage, ingredient swap, novel combination, or exclusivity in a defined scope. The base formula may be shared with other brands; the specific version under the brand’s contract is differentiated.

Private label supplements cover the entire category range: vitamins and minerals, sports nutrition, beauty (collagen, biotin), gut health (probiotics, fiber), sleep and stress (melatonin, ashwagandha), and specialty wellness products. Across formats: capsules, tablets, powders, sachets, gummies, soft gels, and liquids.

The European private label supplements market

The European supplement market is the second-largest in the world after the US, with private label supplements representing a fast-growing segment within it. EU and UK retail value across the supplement industry has reached roughly EUR 30 billion annually, with private label and white label accounting for an increasing share — driven by the rise of D2C supplement brands, the maturity of contract manufacturing in Europe, and tighter regulatory standards that favor experienced suppliers.

What makes the European private label segment distinctive in 2026 is regulatory rigor. EU rules on health claims (EFSA), labeling (Regulation 1169/2011), novel foods, contaminant limits, and GMP/HACCP standards are stricter than US equivalents. Private label supplements manufactured to EU standards are automatically welcome in most other markets globally — the reverse is rarely true.

Within the supplement industry, the brands building durable businesses on private label products typically share a few traits: a clear positioning, a manufacturer who can keep up with growth, formulas with enough customization to defend against direct copycats, and channel strategies that match format and packaging. The manufacturer choice sits upstream of all of that.

Why choose a European private label supplement manufacturer

For supplement brands selling in the EU, UK, Norway, or Switzerland, manufacturing with a European private label supplement manufacturer is both a quality decision and a strategic one.

EU compliance is built in. A reputable European private label supplement manufacturer produces under GMP (Good Manufacturing Practice) and HACCP (Hazard Analysis Critical Control Point) protocols by default. Many also hold ISO 22000 (food safety) and ISO 9001 (quality management) certifications. Distributors, retailers, pharmacy buyers, and platforms increasingly demand these certifications upfront. A non-EU manufacturer often cannot produce the documentation EU buyers require.

EFSA claims and labeling expertise. EFSA maintains the EU register of authorized health claims for vitamin, mineral, and other supplement ingredients. A manufacturer working with EU brands daily knows which claims are approved, which are on hold, and which national authorities layer additional restrictions. A US contract manufacturer typically does not.

Free movement of goods. A private label supplement product released in one EU member state can typically be sold across the bloc with notification rather than separate authorization. The manufacturer should know how to file these notifications, in which countries, and what they cost.

Logistics. Shorter lead times, lower freight, no customs surprises. For a supplement brand selling in Berlin, Paris, or Warsaw, a European supplement manufacturer gets product on shelves weeks faster than one in New Jersey or Guangzhou.

How to choose a private label supplement manufacturer

The catalog and price list tell you almost nothing on their own. These seven criteria separate a serious manufacturing partner from a directory listing.

1. Certifications and audit history

Ask for current GMP and HACCP certificates. Ask which certifying body issued them and when the last audit was. ISO 22000 and ISO 9001 are strong additional signals. For specific markets, look for IFS Food, BRCGS, or organic certifications (Ecocert, Soil Association). For sports nutrition products targeting elite athletes, Informed Sport or NSF Certified for Sport may be required by retailers. A private label supplement manufacturer that hesitates to share GMP or HACCP documents has a reason for hesitating.

2. Format range and production capability

A capable European private label supplement manufacturer should produce across multiple formats: capsules, tablets, powders, sachets, soft gels, gummies, and liquids. Ask which formats run in-house versus subcontract. Subcontracting is not a deal-breaker on its own, but it affects the traceability chain and audit liability sitting on the brand’s side. Within each format, check catalog depth and modification capability. A supplier with 30 capsule formulas and 3 powder blends has a different center of gravity than one with 200+ formulas across formats.

3. Minimum order quantities (MOQ)

Private label MOQs in Europe typically range from 500 to 5,000 units per SKU, depending on format. Capsules and tablets generally have higher MOQs because of equipment changeover costs. Powders and sachets can run lower. Gummies often run higher because of mold and depositing line economics. Exclusivity arrangements sometimes raise MOQs further. For testing a new market or new SKU, look for partners with MOQs in the 500–1,000 unit range.

4. Lead time

A typical private label supplement run, from PO to dispatch, takes 4 to 8 weeks for stock formulas with approved artwork. Add 2 to 4 weeks for custom packaging or label design. Modifications add 4 to 12 weeks for the first run, depending on depth of changes. If a manufacturer quotes “12 weeks minimum” for a near-stock capsule run, that is the moment to ask why.

5. R&D and modification capability

Private label supplements live and die on the manufacturer’s modification capability. A manufacturer with an in-house R&D team and food technologists on staff can refine flavor, dosage, and ingredient profile in weeks. A manufacturer without one cannot, regardless of what their sales rep says. This also matters because the line between “private label with modifications” and “custom formulation” is fuzzy. The right partner walks supplement brands across that line gradually as they grow.

6. EU regulatory support

A real partner provides — without being asked — a technical dossier, ingredient declarations in the format the destination country requires, allergen statements, nutritional analysis, certificates of analysis (COAs) for each batch, and notification support for the markets the brand sells in. Multi-language labels for multi-country launches should be standard, not extra. If paperwork has to be chased, the wrong manufacturer was chosen.

7. Contract terms — IP, exclusivity, exit

The private label supplement contract decides whether the brand has a partner or a vendor. Three clauses matter most: IP ownership (default is manufacturer ownership with brand license — full assignment is negotiable), exclusivity (geographic, channel, time-limited, customer-class, or full — always specify which), and exit terms (what happens at termination: documentation transfer, post-termination obligations, inventory rights). The exit clause is where the relationship is tested.

MOQs, lead times, and costs

Private label supplements have three cost dimensions: upfront modification cost, unit cost, and ongoing maintenance.

Upfront modification. Modifications to a stock supplement formula typically run EUR 5,000–15,000 for light changes (flavor, dosage adjustment) and EUR 15,000–50,000 for deeper work (ingredient swap, novel combination, regulatory revalidation). For a single-modification SKU launching in a single EU market, EUR 15,000–25,000 is typical.

Unit cost. Private label unit costs typically run 5–15% above white label equivalents because of lower volumes per run, modification tooling, and any exclusivity premium. The right manufacturer prices unit cost transparently — cost of goods, packaging, label printing, regulatory documentation, and freight broken out separately.

Lead time reality. First-run lead times for modified formulas range from 8 to 16 weeks. Stock formulas with approved artwork ship in 4 to 8 weeks. Custom packaging adds 2 to 4 weeks on top.

The cost case for modification. A EUR 20,000 modification investment recovered over 50,000 unit lifetime production adds EUR 0.40 per unit. At 10,000 units annual sales, the modification recovers in 2 years; at 50,000 units annually, in 5 months. Volume is the variable that determines whether private label modification is good capital allocation.

EU regulatory considerations

Private label supplements sold in Europe face a layered regulatory environment. The brands that navigate it well treat compliance as a competitive asset, not a cost center.

EFSA health claims. Only claims authorized in the EU Register under Regulation (EC) No 1924/2006 may appear on supplement labels and marketing. Each claim is tied to a specific ingredient at a specific condition of use. A private label manufacturer with deep EU experience will have the authorized claim list for every ingredient in their catalog and will flag anything that does not qualify. Unauthorized claims on a label are a retailer delisting and a regulatory fine waiting to happen.

Labeling — Regulation 1169/2011. Food information to consumers in the EU is governed by Regulation 1169/2011. For supplements, this means: ingredient list in descending order of weight, allergen declarations highlighted in the ingredient list, net quantity, best-before date, storage conditions, recommended daily intake, nutritional information panel, mandatory health claim companion statements, and responsible food business operator name and address. Missing any element can block a product at customs or get it pulled from shelf.

Novel foods. If your private label formula contains an ingredient that was not in common use in the EU before May 1997, it may be classified as a novel food under Regulation (EU) 2015/2283 and require prior authorization. This applies to many botanicals, certain algae-derived ingredients, and specific processing methods. Your manufacturer should flag novel food ingredients before you finalize a formula.

Country-specific notifications. Many EU countries require notification with the national food authority before a supplement can be placed on the market. France (DGCCRF), Italy (Ministry of Health), Belgium (FPS Health), and Spain (AESAN) all have notification requirements. A manufacturer supplying EU brands as a core business should handle or support these filings as part of the service.

Contract clauses that decide ownership

The private label supplement contract is where the commercial relationship is actually defined. Three clauses decide the outcome:

Exclusivity scope. “Exclusive” without qualification means nothing. Specify: geographic (EU only? Germany only?), channel (e-commerce only? pharmacy only?), time-limited (12 months, 24 months?), customer-class (D2C brands only?), or full exclusivity. Vague exclusivity language is discovered to be meaningless exactly when it matters most.

IP assignment versus license. Default in most private label supplement contracts is that the manufacturer owns the formula and grants the brand a license to use it. Full IP assignment to the brand — meaning the brand owns the formula outright — is negotiable but requires explicit language and usually carries volume commitments or upfront fees. Brands that assume ownership without reading the IP clause carefully tend to discover the error at the worst moment: when changing manufacturers.

Exit rights. What happens when the relationship ends? A contract that does not address exit rights leaves the brand exposed. Minimum exit provisions: transfer of all regulatory documentation (COAs, technical dossiers, notification receipts), release of label artwork files, and a defined transition period during which the departing manufacturer continues to supply while the brand finds an alternative. A manufacturer unwilling to include exit provisions is not a partner.

Products overview

Private label supplement brands in Europe build across three main format families. Each has distinct economics, consumer appeal, and operational requirements.

Capsules

Capsules remain the workhorse format for vitamins, minerals, and botanical supplements. They have broad consumer acceptance, a long shelf life, and the widest ingredient compatibility. For sports nutrition applications, they serve single-ingredient stacks (creatine, BCAAs, beta-alanine) and multi-ingredient complexes. For wellness, they cover the full spectrum from basic multivitamins to specialized stress, sleep, and cognition formulas. MOQs typically start at 1,000 units; unit costs compress significantly at 5,000+.

Gummies

Vegan pectin gummies are the fastest-growing format in the European supplement market. They command higher retail prices, have strong repeat purchase rates, and travel well on social media. The manufacturing economics require higher MOQs (typically 1,000 jars minimum) and the process is more capital-intensive than capsules — but the consumer premium offsets the cost. Common private label gummy categories: multivitamin, immunity (vitamin D3 + C + zinc), hair and nails (biotin, zinc), adaptogen (KSM-66® ashwagandha), sleep (melatonin, lemon balm), and sports (creatine monohydrate).

Powders and sachets

Powders in doypack format serve sports nutrition (protein, pre-workout, amino acids), daily greens, and weight management. They are flexible for flavoring and dosing customization, with MOQs starting around 1,000 units. Single-serve sachets are the fastest-growing premium format in DTC supplement subscriptions — the per-unit cost is higher but the unboxing experience and single-serve convenience drive strong consumer loyalty. Collagen, electrolytes, and greens are the most common sachet categories.

Quick FAQ

What is the minimum order for private label supplements in Europe?

Typical MOQs run 500 to 5,000 units per SKU depending on format. Sachets and powders can start lower; tablets and gummies usually run higher. Many European manufacturers standardize at 1,000 units MOQ across powder, sachet, and gummy formats for private label orders.

How much do private label supplements cost?

Modification investment runs EUR 5,000–50,000 depending on depth. Unit costs typically run 5–15% above white label equivalents. Total first-run economics for a private label supplement SKU in Europe usually fall between EUR 25,000 and EUR 60,000 including initial inventory and modification costs.

How long does a private label supplement launch take?

For stock formulas with finished artwork, 4 to 8 weeks. With modifications (custom flavor, dosage adjustment, ingredient swap), the first run takes 8 to 16 weeks. Add 2 to 6 weeks for custom packaging design or country-specific notifications.

Do I own the formula in a private label supplement contract?

By default, no. The supplement manufacturer owns the formula and grants the brand a license. Full IP assignment is negotiable but requires explicit contract language and usually carries cost or volume commitments. Read the IP clause before signing anything.

What certifications should a European private label supplement manufacturer have?

At minimum, GMP and HACCP. ISO 22000, ISO 9001, IFS Food, or BRCGS are strong additional signals. For organic claims, Ecocert or equivalent. For sports nutrition sold to elite athletes, Informed Sport or NSF Certified for Sport may be required by specific retailers or federations.